1. Osteosarcoma of the jaw bones.
- Author
-
Doval DC, Kumar RV, Kannan V, Sabitha KS, Misra S, Vijay Kumar M, Hegde P, Bapsy PP, Mani K, Shenoy AM, and Kumarswamy SV
- Subjects
- Adult, Antineoplastic Agents administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Cause of Death, Chondrocytes pathology, Cisplatin administration & dosage, Combined Modality Therapy, Disease-Free Survival, Female, Fibroblasts pathology, Follow-Up Studies, Humans, Male, Mandibular Neoplasms diagnostic imaging, Mandibular Neoplasms pathology, Maxillary Neoplasms diagnostic imaging, Maxillary Neoplasms pathology, Neoplasm Recurrence, Local pathology, Osteoblasts pathology, Osteolysis diagnostic imaging, Osteosarcoma diagnostic imaging, Osteosarcoma pathology, Osteotomy, Palliative Care, Radiography, Retrospective Studies, Mandibular Neoplasms therapy, Maxillary Neoplasms therapy, Osteosarcoma therapy
- Abstract
Osteosarcoma of the jaw bone is comparatively rare and accounts for about 6.5% of all osteosarcomas. We treated eight cases of osteosarcoma of the jaw bone involving the mandible and maxilla in equal proportions between 1986-1992. The median age was 31 years and male: female ratio was 5:3. Swelling and bony expansion were the most common presentations. Radiologically six patients had lytic lesions, and histopathologically they were osteoblastic (n = 4), chondroblastic (n = 3) and fibroblastic (n = 1). Three patients, two with mandibular and one with maxillary osteosarcoma underwent radical surgery and six courses of cisplatinum-based chemotherapy. All were alive and disease free 24, 30, and 54 months after treatment. Histologically all three were chondroblastic. Five patients had incomplete or palliative treatment. All patients died of progressive or locally recurrent disease within 2 years.
- Published
- 1997
- Full Text
- View/download PDF